Sangamo Therapeutics
SGMO
NASDAQ
IPO2000
about SGMO
Sangamo Therapeutics is a biotechnology company focused on gene therapy and genome editing, developing innovative treatments for genetic disorders and rare diseases such as hemophilia and metabolic conditions.
| type | open | high | low |
market cap |
volume |
|---|---|---|---|---|---|
| stock | $0.40 | $0.41 | $0.38 | $147.22M | 3.46M |
| eps |
price to earnings |
price to sales |
operating margin |
profit margin |
yield |
| -$0.11 | n/a | 199.00 | -6119.28% | -6012.05% | 0% |